Dr. Donahue has extensive experience in every phase of drug development and has served in lead statistical roles in research and development for products in allergy, analgesia, epilepsy, schizophrenia, Alzheimer’s disease, depression, addiction, surgery, orthopedics, and other areas. Dr. Donahue serves on the editorial board of the journal, Therapeutic Innovation & Regulatory Science. Dr. Donahue is currently Senior Director for Statistics at Biomimetic Therapeutics, Inc and Adjunct Associate Professor in the Department of Biostatistics at Vanderbilt University Medical Center. Dr. Donahue earned his BS in Mathematics from the University of Dayton and his PhD in Statistics from Colorado State University.